Department of Parasitology, Benha Faculty of Medicine, Benha University, Egypt.
Division of International Infectious Diseases Control, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-Naka, Kita-Ku, Okayama 700-8530, Japan.
Parasites Hosts Dis. 2023 Aug;61(3):251-262. doi: 10.3347/PHD.22154. Epub 2023 Aug 21.
Schistosomiasis causes significant morbidity and mortality worldwide. This study aimed to assess the effect of schistosomula lung antigen preparation (SLAP) and soluble egg antigen (SEA) on a murine schistosomiasis mansoni model. Ninety laboratory-bred male Swiss albino mice were divided into 6 groups. Two doses of the vaccine were given at 2-week intervals. All mice were subcutaneously infected with 80±10 Schistosoma mansoni cercariae 2 weeks after the last vaccination dose. They were sacrificed 7 weeks post-infection. Parasitological and histopathological studies were conducted to assess the effect of inoculated antigens (single or combined). The results showed that the combination of SLAP and SEA (combination group) led to a significant reduction in worm burden (65.56%), and liver and intestine egg count (59% and 60.59%, respectively). The oogram pattern revealed a reduction in immature and mature eggs (15±0.4 and 10±0.8, respectively) and an increased number of dead eggs in the combination group (P<0.001). In terms of histopathological changes, the combination group showed notably small compact fibrocellular egg granuloma and moderate fibrosis in the liver. A high percentage of destroyed ova was observed in the intestine of the combination group. This study demonstrates for the first time the prophylactic effect of combined SLAP and SEA vaccine. The vaccine induced a significant reduction in the parasitological and pathological impacts of schistosomiasis mansoni in hepatic and intestinal tissues, making it a promising vaccine candidate for controlling schistosomiasis.
血吸虫病在全球范围内造成了重大的发病率和死亡率。本研究旨在评估曼氏血吸虫尾蚴肺抗原制剂(SLAP)和可溶性虫卵抗原(SEA)对曼氏血吸虫病小鼠模型的影响。90 只实验室饲养的雄性瑞士白化病小鼠被分为 6 组。疫苗分两剂,每两周接种一次。所有小鼠在最后一次接种后 2 周经皮下感染 80±10 条曼氏血吸虫尾蚴。感染后 7 周处死它们。进行寄生虫学和组织病理学研究以评估接种抗原(单一或组合)的效果。结果表明,SLAP 和 SEA 的组合(组合组)导致虫荷(65.56%)和肝、肠卵计数(分别为 59%和 60.59%)显著减少。卵图模式显示未成熟和成熟卵的数量减少(分别为 15±0.4 和 10±0.8),组合组的死亡卵数量增加(P<0.001)。就组织病理学变化而言,组合组显示肝中纤维细胞致密的小纤维细胞性卵肉芽肿和中度纤维化明显。组合组肠中观察到大量卵破坏。本研究首次证明了联合 SLAP 和 SEA 疫苗的预防效果。该疫苗显著降低了曼氏血吸虫在肝和肠道组织中的寄生虫学和病理学影响,使其成为控制血吸虫病的有前途的候选疫苗。